Searched for
THEMIS
US stocks today: US market rebounds as oil drops despite Middle East tensionsWall Street indexes climbed at Tuesday's market open as oil prices fell despite heightened Middle East tensions. The Dow Jones Industrial A...- Sensex rises! But these stocks are down 5% or more on BSEIn the Nifty pack, 40 stocks were trading in the green, while 8 stocks were trading in the red.
- Corporate actions this week: Gujarat Themis Biosyn to go ex-split, RMC Switchgear ex-bonus and moreA stock split is usually done to increase the liquidity of the stock in the market. On the ex-split date, investors who are holding the sto...
- Technical breakthrough: PC Jeweller, Dwarikesh Sugar among 9 other stocks cross 1000-day SMASeveral smallcap stocks have crossed their 100-day Simple Moving Average (SMA), offering potential growth opportunities. Notable performers...
- Fantastic 4 multibagger stocks that have given at least 25% return in last 4 years. Will history repeat?Four consistent performers in the Indian stock market have been identified through a screener search, each having delivered over 25% annual...
- Smallcap pharma multibagger stock announces 1:5 stock split, declares dividendGujarat Themis Biosyn, an India-based pharma firm, has announced a 1:5 stock split and a dividend of Rs 1 for the financial year ended Marc...
- Stock market update: Stocks that hit 52-week highs on NSEVesuvius India, Repro India, DJ Mediaprint & Logi, Themis Medicare and Sotac Pharmaceutical, hit their fresh 52-week highs at 10:35AM.
- Buy Gujarat Themis Biosyn, target price Rs 909: HDFC SecuritiesGujarat Themis Biosyn Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap for the year ending 31-Mar-2022.
- Corporate Radar: Milkfood to go ex-dividend; Chandra Prabhu International stock split & moreShares of Chandra Prabhu International (Rs 10 to Rs 2) will turn ex-split. A meeting of the board of directors of Indo Cotspin is scheduled...
- Corporate Radar: Maruti Suzuki, Soma Textiles AGMs; SpiceJet Q1 results and moreWednesday is the record date for dividend by Data Patterns (India) (Rs 3.5 per share), Ion Exchange (Rs 10 per share), RSWM (Rs 25 per shar...
- Themis Medi bets big on antiviral drug for CovidThemis had launched inosine pranobex under brand name Viralex in June this year. Despite the drug not figuring in the government's Covid tr...
- Themis Medicare’s anti-viral COVID drug gets DCGI nodMumbai-based pharmaceutical company Themis Medicare’s anti-viral drug Viralex has received Drugs Controller General of India’s (DCGI) appro...
- Themis gets Drug Controller’s nod to launch Inosine Pranobex a novel medicine to treat Covid19, A Viral Infection
- Merck leaps into COVID-19 development fray with vaccine, drug dealsIt also announced a partnership with privately-held Ridgeback Biotherapeutics to develop an experimental oral antiviral drug against COVID-...
- Bitcoin surges past $7k to extend record rallyBitcoin's meteoric rise is attracting a ton of attention. Is it ready for the mainstream?
- Themis Medicare inks pact with Nevakar for injectable productsThe New Jersey-based specialty pharmaceutical firm Navakar has expertise in commercialising pharma products in the US as well as global mar...
- Indian pharma company may sue drug controller over safety of Novartis painkillerNovartis’ Voveran 1ml and Themis' Aquadol have competed with Troikaa’s own injection to manage pain, Dynapar AQ, since their launch in 2013.
- Startups now taking to Twitter and Facebook to raise fundsMumbai Angels, Kae Capital, Rehan Yar Khan’s Orios Ventures, Indian Angel Network and Ankur Capital will be participating in the exercise.
- Jacob Ballas buys stake in ThemisMauritius-based private equity fund New York Life Investment Management Jacob Ballas India Fund has acquired a “minority” stake in Mumbai-b...
- Aventis Pharma, Themis sign tech dealAventis Pharma and Themis Laboratories have signed a technology transfer agreement for fixed-dose combinations comprising glibenclamide (Da...
Load More
